RUA Life Sciences has announced external financing for its structural heart business, which will spinout to become a separate business, RUA Structural Heart (RSH). RSH will receive £3.0m of funding from the Leducq Foundation, which will allow the business to develop its mitral valve programme to first-in-human readiness. The convertible loan financing and spinout will see RUA capitalise its historic investment in the heart valve programme while retaining 100% equity ownership ahead of any future ....
